Antimycobacterial activities of oxazolidinones: A review

Infectious Disorders - Drug Targets

Volumn 6, Issue 4, 2006, Pages 343-354

  Sood, Ruchi ^a   Bhadauriya, T ^a   Rao, M ^a   Gautam, R ^a   Malhotra, S ^a   Barman, T K ^a   Upadhyay, D J ^a   Rattan, A ^b  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b Caribbean Epidemiology Centre   (Trinidad and Tobago)

Author keywords

Antimycobacterial; CFU GM; Linezolid; MDR; Myleosuppression; Oxazolidinones; Ranbezolid; RBx 8700

Indexed keywords

ALANINE AMINOTRANSFERASE; AZITHROMYCIN; CEPHALOSPORIN; CGP 29861; CHLORAMPHENICOL; CLARITHROMYCIN; DA 7867; DOXORUBICIN; EPEREZOLID; ETHAMBUTOL; ISONIAZID; LINCOMYCIN; LINEZOLID; N [[3 (4 ACETYLPHENYL) 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE; N [[3 [4 (METHYLSULFINYL)PHENYL] 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE; OXAZOLIDINONE DERIVATIVE; PNU 100480; PNU 177553; POSIZOLID; QUINOLONE DERIVATIVE; RANBEZOLID; RBX 8700; RIFAMPICIN; RWJ 334181; RWJ 337813; SPARFLOXACIN; TUBERCULOSTATIC AGENT; U 100480; U 101244; U 101603; U 10163;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COLONY FORMING UNIT GM; DIARRHEA; DRUG ABSORPTION; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; ERYTHROCYTE COUNT; HEADACHE; HEMATOCRIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOOSE FECES; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM AURUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM PHLEI; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM VACCAE; MYCOBACTERIUM XENOPEI; NAUSEA; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; THROMBOCYTE COUNT; TUBERCULOSIS; VOMITING;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM; OXAZOLIDINONES; TUBERCULOSIS;

EID: 33845452011     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152606779025860     Document Type: Review

References (43)

1. Barbachyn, M.R.; Hutchinson, D.K.; Brickner, S.J.; Cynamon, M.H.; Kilburn, J.O.; Klemens, S.P.; Glickman, S.E.; Grega, K.C.; Hendges, S.K.; Toops, D.S.; Ford, C.W.; Zurenko, G.E. J. Med. Chem., 1996, 39, 680.
2. Eustice, D.C.; Feldman, P.A.; Zajac, I.; Slee, A.M. Antimicrob. Agents Chemother., 1988, 32, 1218.
3. Daly, J.S.; Eliopoulos, G.M.; Reiszner, E.; Moellering, R.C. Jr. J. Antimicrob. Chemother., 1988, 21, 721.
4. Shinabarger, D.L.; Marotti, K.R.; Murray, R.W.; Lin, A.H.; Melchior, E.P.; Swaney, S.M.; Dunyak, D.S.; Demyan, W.F.; Buysse, J.M. Antimicrob. Agents Chemother., 1997, 41, 2132.
5. Ashtekar, D.R.; Costa-Periera, R.; Shrinivasan, T.; Iyyer, R.; Vishvanathan, N.; Rittel, W.S. Diagn. Microbiol. Infect. Dis., 1991, 14, 465.
6. Wallace, Jr. R.J.; Brown-Elliott, B.A.; Ward, S.C.; Crist, C.J.; Mann, L.B.; Wilson, R.W. Antimicrob. Agents Chemother., 2001, 45, 764.
7. Cynamon, M.H.; Klemens, S.P.; Sharpe, C.A.; Chase, S. Antimicrob Agents Chemother., 1999, 43, 189.
8. Alcalá, L.; Ruiz-Serrano, M. J.; Pérez-Fernández Turégano, C.; García de Viedma, D.; Díaz-Infantes, M.; Marín-Arriaza, M.; Bouza, E. Antimicrob. Agents Chemother., 2003, 47, 416.
9. Zurenko, G.E.; Yagi, B.H.; Schaadt, R.D.; Allison, J.W.; Kilburn, J.O.; Glickman, S.E.; Hutchinson, D.K.; Barbachyn, M.R.; Brickner, S.J. Antimicrob. Agents Chemother., 1996, 40, 839.
10. Cynamon, M.H.; Zhang, Y.; Harpster, T.; Cheng, S.; DeStefano, M.S. Antimicrob. Agents Chemother., 1999, 43, 2922.
11. Valencia, M.E.; Moreno, V.; Laguna, F.; Gonzalez-Lahoz, J.M. Enferm. Infect. Microbiol. Clin., 2001, 19, 37.
12. Bobkova, E.V.; Yan, Y.P.; Jordan, D.B.; Kurilla, M.G.; Pompliano, D.L.J. Biol. Chem., 2003, 278, 9802.
13. Zhou, C.C.; Swaney, S.M.; Shinabarger, D.L.; Stockman, B.J. Antimicrob. Agents Chemother., 2002, 46, 625.
14. Lin, A.H.; Murray, R.W.; Vidmar, T.J.; Marotti, K.R. Antimicrob. Agents Chemother., 1997, 41, 2127.
15. Bozdogan, B.; Appelbaum, P.C. Int. J. Antimicrob. Agent, 2004, 23, 113.
16. Swaney, S.M.; Aoki, H.; Ganoza, M.C.; Shinabarger, D.L. Antimicrob. Agents Chemother., 1998, 42, 3251.
17. Aoki, H.; Dekany, K.; Adams, S.L., Ganoza, M.C. J. Biol. Chem., 1997, 272, 32254.
18. Slee, A. M.; Wuonola, M.A.; McRipley, R. J.; Zajac, I.; Zawada, M. J.; Bartholomew, P. T.; Gregory, W. A.; Forbes, M. Antimicrob. Agents Chemother., 1987, 31, 1791.
19. Brickner, S. J.; Hutchinson, D. K.; Barbachyn, M. R.; Manninen, P. R.; Ulanowicz, D. A.; Garmon, S. A.; Grega, K. C.; Hendges, S. K.; Toops, D. S.; Ford, C. W.; Zurenko. G. E. J. Med. Chem., 1996, 39, 673.
20. Brumfitt, W.; Hamilton-Miller, J.M.T. J. Antimicrob. Chemother., 1980, 21, 711.
21. Sbardella, G.; Mai, A.; Artico, M.; Loddo, R.; Setzu, M.G.; La Colla, P. Bioorg. Med. Chem. Lett., 2004, 14, 1537.
22. Rodriguez, J.C.; Ruiz, M.; Lopez, M.; Royo, G. Int. J. Antimicrob. Agents, 2002, 20, 464.
23. Wallace, R. J. Jr.; Brown-Elliott, B. A.; Ward, S. C.; Crist, C. J.; Mann, L. B.; Wilson, R. W. Antimicrob. Agents Chemother., 2001, 45, 764.
24. Hadjiangelis, N.P.; Leibert, E.; Harkin, T.J. Am. J. Respir. Crit. Care Med., 2003, 167, A868.
25. Clemett, D.; Markham, A. Drugs, 2000, 59, 815.
26. Norrby, R. Expert Opin. Pharmacother., 2001, 2, 293.
27. Hutchinson, D.K. Expert Opin. Ther. Patients, 2004, 14, 1309.
28. Padget, S.; Foleno, B.D.; Boggs, C.M.; Goldschmidt, R. M.; Hlasta, D. J.; Weidner-Wells, M. A.; Werblood, H. M.; Wira, E.; Bush, K.; Macielag, M. J. Bioorg. Med. Chem. Lett., 2003, 13, 4173.
29. Mehta, A.; Arora, S. K.; Das, B.; Ray, A.; Rudra, S.; Rattan, A. WO 03/ 007870 A2.
30. Mehta, A.; Arora, S. K.; Das, B.; Ray, A.; Rudra, S.; Rattan, A. WO 02/ 06278.
31. Das, B.; Mehta, A.; Rattan, A. WO 03/097059 A1.
32. Mehta, A.; Rudra, S.; RajaRao, A.V.S.; Yadav, A. S.; Rattan, A. WO 2004/ 014392 A1.
33. Rao, M.; Sood, R.; Malhotra, S.; Fatima, T.; Upadhyay, D.J.; Rattan, A. J. Chemother., 2005. Accepted. In communication.
34. Sood, R.; Rao, M.; Singhal, S.; Rattan, A. Int. J. Antimicrob. Agents, 2005, 25, 464.
35. Zyvox package insert. (January 2002). Pharmacia & Upjohn Company, Kalamazoo, MI, USA
36. Slatter, J.G.; Stalker, D.J.; Feenstra, K.L.; Welshman, I.R.; Bruss, J.B.; Sams, J.P. Drug Metab. Dispos., 2001, 29, 1136.
37. Cynamon, M.H.; Klemens, S.P.; Sharpe, C.A.; Chase, S. Antimicrob. Agents Chemother., 1999, 43, 1189.
38. Rattan, A. Drugs Future, 2003, 28, 1070.
39. Zurenko, G.E.; Ford, C.W.; Hutchinson, D.K.; Brickner, S.J.; Barbachyn, M.R. Expert Opin. Investig. Drugs, 1997, 6,151.
40. French, G. J. Antimicrob. Chemother., 2003, 51 (Suppl S2), ii45.
41. Noble, C.; Sina, J.F. In Vitro Toxicol., 1993, 6,187.
42. Mueller, I.; Neflel. K.; Walti, M.; Hauser, S.; Arrenbrecht, S. Med. Wochenschr., 1983, 113, 1471.
43. Deldar, A.; Lewis, H.; Bloom, J.; Weiss, L. Fundam. Appl. Toxicol., 1988, 11, 450.